Chad M. Robins files multiple Rule 144 notices for ADPT (ADPT)
Rhea-AI Filing Summary
Adaptive Biotechnologies (ADPT) insider Chad M. Robins reported multiple proposed sales of Common Stock under Rule 144. The excerpt lists repeated dispositions of 41,666 shares on 11/26/2025, 12/01/2025, 01/05/2026 and 02/02/2026, plus a 35,736-share entry on 11/26/2025. Each row shows a gross sale amount in dollars alongside the share counts.
Positive
- None.
Negative
- None.
Insights
Multiple Rule 144 sale notices from the same insider, all routine disclosures.
These entries list several proposed dispositions by Chad M. Robins, mainly 41,666 shares on four separate dates and one 35,736 share entry, with per-row dollar amounts shown. Rule 144 notices are disclosure-driven and do not by themselves confirm completed open-market trades.
Impact depends on whether these sales were executed; subsequent Form 4/Form 5 or broker records would confirm actual transactions and proceeds. Timing and final cash‑flow treatment are not stated in the excerpt.